Basic Study
Copyright ©The Author(s) 2024.
World J Orthop. Nov 18, 2024; 15(11): 1075-1087
Published online Nov 18, 2024. doi: 10.5312/wjo.v15.i11.1075
Figure 1
Figure 1 Schematic representation of the procedure for creating the defect in the calvarial bone. The bone defects were created bilaterally, both equidistant from the median sagittal suture, using a 6 mm diameter trephine surgical drill.
Figure 2
Figure 2 Expression of IL-1β and IL-6 genes. A and B: Expression of IL-1β: Mean and standard deviation column graph with the confidence intervals in their respective groups (G1-G9); C and D: Expression of IL-6: Mean and standard deviation column graph with the confidence intervals in their respective groups (G1-G9). G1: Control; G2: Blood clot and Scaffold; G3: Blood clot + Scaffold + Melatonin 1 μg; G4: Blood clot + Scaffold + Melatonin 10 μg; G5: Blood clot + Scaffold + Melatonin 100 μg; G6: Blood clot + Scaffold + Melatonin 1 μg + rhBMP2; G7: Blood clot + Scaffold + Melatonin 10 μg + rhBMP2; G8: Blood clot + Scaffold + Melatonin 100 μg + rhBMP2; G9: Blood clot + Scaffold + rhBMP2.
Figure 3
Figure 3 Expression of IL-10 and TNF-α genes. A and B: Expression of IL-10: Mean and standard deviation column graph with the confidence intervals in their respective groups (G1-G9); C and D: Expression of TNF-α: Mean and standard deviation column graph with the confidence intervals in their respective groups (G1-G9). G1: Control; G2: Blood clot and Scaffold; G3: Blood clot + Scaffold + Melatonin 1 μg; G4: Blood clot + Scaffold + Melatonin 10 μg; G5: Blood clot + Scaffold + Melatonin 100 μg; G6: Blood clot + Scaffold + Melatonin 1 μg + rhBMP2; G7: Blood clot + Scaffold + Melatonin 10 μg + rhBMP2; G8: Blood clot + Scaffold + Melatonin 100 μg + rhBMP2; G9: Blood clot + Scaffold + rhBMP2.
Figure 4
Figure 4 Expression of RANK, RANKL and OPG markers. A and B: Expression of RANK: Mean and standard deviation column graph with the confidence intervals in their respective groups (G1-G9); C and D: Expression of RANKL: Mean and standard deviation column graph with the confidence intervals in their respective groups (G1-G9); E and F: Expression of OPG: Mean and standard deviation column graph with the confidence intervals in their respective groups (G1-G9). G1: Control; G2: Blood clot and Scaffold; G3: Blood clot + Scaffold + Melatonin 1 μg; G4: Blood clot + Scaffold + Melatonin 10 μg; G5: Blood clot + Scaffold + Melatonin 100 μg; G6: Blood clot + Scaffold + Melatonin 1 μg + rhBMP2; G7: Blood clot + Scaffold + Melatonin 10 μg + rhBMP2; G8: Blood clot + Scaffold + Melatonin 100 μg + rhBMP2; G9: Blood clot + Scaffold + rhBMP2.
Figure 5
Figure 5 Expression of MMP-1 and MMP-2 markers. A and B: Expression of MMP-1: Mean and standard deviation column graph with the confidence intervals in their respective groups (G1-G9); C and D: Expression of MMP-2: Mean and standard deviation column graph with the confidence intervals in their respective groups (G1-G9). G1: Control; G2: Blood clot and Scaffold; G3: Blood clot + Scaffold + Melatonin 1 μg; G4: Blood clot + Scaffold + Melatonin 10 μg; G5: Blood clot + Scaffold + Melatonin 100 μg; G6: Blood clot + Scaffold + Melatonin 1 μg + rhBMP2; G7: Blood clot + Scaffold + Melatonin 10 μg + rhBMP2; G8: Blood clot + Scaffold + Melatonin 100 μg + rhBMP2; G9: Blood clot + Scaffold + rhBMP2.
Figure 6
Figure 6 Expression of MMP-8 and MMP-13 markers. A and B: Expression of MMP-8: Mean and standard deviation column graph with the confidence intervals in their respective groups (G1-G9); C and D: Expression of MMP-13: Mean and standard deviation column graph with the confidence intervals in their respective groups (G1-G9). G1: Control; G2: Blood clot and Scaffold; G3: Blood clot + Scaffold + Melatonin 1 μg; G4: Blood clot + Scaffold + Melatonin 10 μg; G5: Blood clot + Scaffold + Melatonin 100 μg; G6: Blood clot + Scaffold + Melatonin 1 μg + rhBMP2; G7: Blood clot + Scaffold + Melatonin 10 μg + rhBMP2; G8: Blood clot + Scaffold + Melatonin 100 μg + rhBMP2; G9: Blood clot + Scaffold + rhBMP2.